Not logged inEnd points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Degtyarev, Evgeny; Bolanos, Natacha; Brody, Joshua D.; Buchbinder, Aby; Buyse, Marc; Fuchs, Miriam; Halabi, Susan; Hemmings, Robert; Masood, Aisha; Newsome, Simon; Saxton, Claire; Warwick, Lorna; Yateman, Nigel A.; Zuber, Emmanuel .png)
Share.png)
SaveMethodology for Good Machine Learning with Multi-Omics DataCoroller, Thibaud; Sahiner, Berkman; Amatya, Anup; Gossmann, Alexej; Karagiannis, Konstantinos; Moloney, Conor; Samala, Ravi K.; Santana-Quintero, Luis; Solovieff, Nadia; Wang, Craig; Amiri-Kordestani, Laleh; Cao, Qian; Cha, Kenny H.; Charlab, Rosane; Cross, Frank H.; Hu, Tingting; Huang, Ruihao; Kraft, Jeffrey; Krusche, Peter; Li, Yutong; Li, Zheng; Mazo, Ilya; Paul, Rahul; Schnakenberg, Susan; Serra, Paolo; Smith, Sean; Song, Chi; Su, Fei; Tiwari, Mohit; Vechery, Colin; Xiong, Xin; Zarate, Juan Pablo; Zhu, Hao; Chakravartty, Arunava; Liu, Qi; Ohlssen, David; Petrick, Nicholas; Schneider, Julie A.; Walderhaug, Mark; Zuber, Emmanuel Share Save Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma:: results of a randomized phase II studyPozzo, C; Barone, C; Szanto, J; Padi, E; Pesche, C; Bükki, J; Gorbunova, V; Valvere, V; Zaluski, J; Biakhov, M; Zuber, E; Jacques, C; Bugat, R Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
